Merck KGaA Statistics

Total Valuation

Merck KGaA has a market cap or net worth of GBP 42.17 billion. The enterprise value is 48.19 billion.

Market Cap	42.17B
Enterprise Value	48.19B

Important Dates

The last earnings date was Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	Apr 28, 2025

Share Statistics

Current Share Class	129.24M
Shares Outstanding	n/a
Shares Change (YoY)	+0.14%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	129.20M

Valuation Ratios

The trailing PE ratio is 17.89 and the forward PE ratio is 12.86.

PE Ratio	17.89
Forward PE	12.86
PS Ratio	2.36
PB Ratio	1.69
P/TBV Ratio	9.57
P/FCF Ratio	20.65
P/OCF Ratio	12.27
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.74, with an EV/FCF ratio of 23.60.

EV / Earnings	20.44
EV / Sales	2.69
EV / EBITDA	9.74
EV / EBIT	13.75
EV / FCF	23.60

Financial Position

The company has a current ratio of 1.31, with a Debt / Equity ratio of 0.29.

Current Ratio	1.31
Quick Ratio	0.69
Debt / Equity	0.29
Debt / EBITDA	1.48
Debt / FCF	3.56
Interest Coverage	17.86

Financial Efficiency

Return on equity (ROE) is 9.75% and return on invested capital (ROIC) is 6.79%.

Return on Equity (ROE)	9.75%
Return on Assets (ROA)	5.26%
Return on Invested Capital (ROIC)	6.79%
Return on Capital Employed (ROCE)	10.44%
Revenue Per Employee	284,842
Profits Per Employee	37,656
Employee Count	59,020
Asset Turnover	0.43
Inventory Turnover	1.88

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.24% in the last 52 weeks. The beta is 0.64, so Merck KGaA's price volatility has been lower than the market average.

Beta (5Y)	0.64
52-Week Price Change	-32.24%
50-Day Moving Average	119.52
200-Day Moving Average	141.23
Relative Strength Index (RSI)	43.19
Average Volume (20 Days)	92,329

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Merck KGaA had revenue of GBP 17.83 billion and earned 2.36 billion in profits. Earnings per share was 5.42.

Revenue	17.83B
Gross Profit	10.59B
Operating Income	3.48B
Pretax Income	3.01B
Net Income	2.36B
EBITDA	4.92B
EBIT	3.48B
Earnings Per Share (EPS)	5.42

Full Income Statement

Balance Sheet

The company has 1.36 billion in cash and 7.28 billion in debt, giving a net cash position of -5.92 billion.

Cash & Cash Equivalents	1.36B
Total Debt	7.28B
Net Cash	-5.92B
Net Cash Per Share	n/a
Equity (Book Value)	25.01B
Book Value Per Share	57.37
Working Capital	2.43B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.44 billion and capital expenditures -1.39 billion, giving a free cash flow of 2.04 billion.

Operating Cash Flow	3.44B
Capital Expenditures	-1.39B
Free Cash Flow	2.04B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 59.39%, with operating and profit margins of 19.53% and 13.22%.

Gross Margin	59.39%
Operating Margin	19.53%
Pretax Margin	16.86%
Profit Margin	13.22%
EBITDA Margin	27.57%
EBIT Margin	19.53%
FCF Margin	11.45%

Dividends & Yields

This stock pays an annual dividend of 1.87, which amounts to a dividend yield of 1.62%.

Dividend Per Share	1.87
Dividend Yield	1.62%
Dividend Growth (YoY)	-0.46%
Years of Dividend Growth	n/a
Payout Ratio	36.37%
Buyback Yield	-0.14%
Shareholder Yield	1.48%
Earnings Yield	5.59%
FCF Yield	4.84%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 30, 2014. It was a forward split with a ratio of 2.

Last Split Date	Jun 30, 2014
Split Type	Forward
Split Ratio	2

Scores

Merck KGaA has an Altman Z-Score of 3.48.

Altman Z-Score	3.48
Piotroski F-Score	n/a